Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Coll Cardiol ; 48(1): 81-8, 2006 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-16814652

RESUMO

OBJECTIVES: The purpose of the present study was to validate the diagnostic accuracy of optical coherence tomography (OCT), integrated backscatter intravascular ultrasound (IB-IVUS), and conventional intravascular ultrasound (C-IVUS) for tissue characterization of coronary plaques and to evaluate the advantages and limitations of each of these modalities. BACKGROUND: The diagnostic accuracy of OCT for characterizing tissue types is well established. However, comparisons among OCT, C-IVUS, and IB-IVUS have not been done. METHODS: We examined 128 coronary arterial sites (42 coronary arteries) from 17 cadavers; IVUS and OCT images were acquired on the same slice as histology. Ultrasound signals were obtained using an IVUS system with a 40-MHz catheter and digitized at 1 GHz with 8-bit resolution. The IB values of the ultrasound signals were calculated with a fast Fourier transform. RESULTS: Using histological images as a gold standard, the sensitivity of OCT for characterizing calcification, fibrosis, and lipid pool was 100%, 98%, and 95%, respectively. The specificity of OCT was 100%, 94%, and 98%, respectively (Cohen's kappa = 0.92). The sensitivity of IB-IVUS was 100%, 94%, and 84%, respectively. The specificity of IB-IVUS was 99%, 84%, and 97%, respectively (Cohen's kappa = 0.80). The sensitivity of C-IVUS was 100%, 93%, and 67%, respectively. The specificity of C-IVUS was 99%, 61%, and 95%, respectively (Cohen's kappa = 0.59). CONCLUSIONS: Within the penetration depth of OCT, OCT has a best potential for tissue characterization of coronary plaques. Integrated backscatter IVUS has a better potential for characterizing fibrous lesions and lipid pools than C-IVUS.


Assuntos
Doença da Artéria Coronariana/diagnóstico por imagem , Ultrassonografia de Intervenção , Calcinose/diagnóstico por imagem , Calcinose/patologia , Doença da Artéria Coronariana/patologia , Vasos Coronários/diagnóstico por imagem , Vasos Coronários/patologia , Fibrose/diagnóstico por imagem , Fibrose/patologia , Humanos , Técnicas In Vitro , Variações Dependentes do Observador , Valor Preditivo dos Testes , Sensibilidade e Especificidade , Tomografia de Coerência Óptica , Túnica Íntima/diagnóstico por imagem , Túnica Íntima/patologia
2.
J Nucl Cardiol ; 12(4): 460-5, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16084435

RESUMO

The vast majority of acute coronary events are attributed to rupture or erosion of high-risk or vulnerable plaques. Novel imaging techniques are being actively sought that can detect quiescent vulnerable features within coronary plaque and thereby identify populations at risk, monitor plaque progression, and target therapy appropriately. Optical coherence tomography is an intravascular imaging modality capable of detecting and characterizing coronary plaque in vivo. Recently, optical coherence tomography quantification of macrophage infiltration within atherosclerotic plaque ex vivo was demonstrated. Application of this technique to clinical practice yields a hybrid image incorporating plaque morphology with a measure of biologic activity. In a recently conducted clinical study assessing macrophage distributions in patients, evidence supporting both the vulnerable plaque model and the hypothesis of multifocal inflammatory risk, linked by the common thread of increased macrophage infiltration, has been found. These results suggest that elevated multifocal coronary macrophage content, present both in culprit lesions and at remote sites, serves as a background for heightened risk. Superimposed on this inflammatory background, local increases in macrophage content, particularly at the cap surface and at areas at high risk for rupture, further promote the instability of individual lesions.


Assuntos
Vasos Sanguíneos/patologia , Doença da Artéria Coronariana/patologia , Macrófagos/patologia , Tomografia de Coerência Óptica/métodos , Humanos
3.
Am J Physiol Heart Circ Physiol ; 288(6): H2995-3000, 2005 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15897329

RESUMO

The purpose of this study is to evaluate the feasibility of percutaneous antegrade myocardial gene transfer (PAMGT). A consistent and safe technique for in vivo gene transfer is required for clinical application of myocardial gene therapy. PAMGT with concomitant coronary venous blockade was performed in 12 swine. The myocardium was preconditioned with 1 min of occlusion of the left anterior descending and left circumflex arteries. The anterior interventricular vein was occluded during left anterior descending artery delivery, and the great cardiac vein at the entrance of the middle cardiac vein was occluded during left circumflex artery delivery. With arterial and venous balloons inflated (3 min) and after adenosine (25 mug) injection, PAMGT was performed by antegrade injection of an adenoviral solution (1 ml of 10(11) plaque-forming units in each coronary artery) carrying beta-galactosidase or saline through the center lumen of the angioplasty balloon. In one set of animals, PAMGT was performed with selective coronary vein blockade (n = 9); in another set of animals, PAMGT was performed without coronary vein blockade (n = 5). At 1 wk after gene delivery, the animals were killed. Quantitative beta-galactosidase analysis was performed in the left and right ventricular walls. PAMGT was successfully performed in all animals with and without concomitant occlusion of the coronary veins. Quantitative beta-galactosidase analysis showed that PAMGT with coronary blockade was superior to PAMGT without coronary blockade. beta-Galactosidase activity increased significantly in the beta-galactosidase group compared with the saline group: 1.34 +/- 0.18 vs. 0.81 +/- 0.1 ng (P

Assuntos
Cateterismo Cardíaco/métodos , Técnicas de Transferência de Genes , Genes Virais/genética , Coração , beta-Galactosidase/genética , Adenoviridae/genética , Animais , Angiografia Coronária , DNA Complementar/genética , Terapia Genética/métodos , Vetores Genéticos , Proteínas Recombinantes/metabolismo , Suínos , beta-Galactosidase/metabolismo
4.
Catheter Cardiovasc Interv ; 65(3): 394-404, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15822113

RESUMO

The goal of this study was to investigate the feasibility of a catheter-based ventricle-to-coronary vein bypass (VPASS) in order to achieve retrograde myocardial perfusion by a conduit (VSTENT) from the left ventricle (LV) to the anterior interventricular vein (AIV). Percutaneous coronary venous arterialization has been proposed as a potential treatment strategy for otherwise untreatable coronary artery disease. In an acute setting, the VSTENT implant was deployed percutaneously using the VPASS procedure in five swine. Coronary venous flow and pressure patterns were measured before and after VSTENT implant deployment with and without AIV and left anterior descending artery (LAD) occlusion. In a separate chronic pilot study, the VPASS procedure was completed on two animals that had a mid-LAD occlusion or LAD stenosis. At day 30 post-VPASS procedure, left ventriculography and magnetic resonance imaging (MRI) were performed to assess the patency and myocardial viability of the VSTENT implants. Pre-VSTENT implantation, the mid-AIV systolic wedge pressure was significantly lower than LV systolic pressure during AIV blockage (46 +/- 19 vs. 90 +/- 16 mm Hg; P < 0.01). The VSTENT implant deployment was performed without complication and achieved equalization of the AIV and LV systolic pressures and creation of retrograde flow in the distal AIV (maximal flow velocity: 37 +/- 7 cm/sec). At day 30 post-VPASS procedure, left ventriculography showed VSTENT implant patency. MRI perfusion images demonstrated myocardial viability even with an LAD occlusion. Coronary retrograde perfusion using the VPASS procedure is feasible and may represent a potential technique for end-stage myocardial ischemia.


Assuntos
Cateteres de Demora , Vasos Coronários , Ventrículos do Coração , Revascularização Miocárdica/instrumentação , Animais , Imageamento por Ressonância Magnética , Modelos Animais , Revascularização Miocárdica/métodos , Stents , Suínos , Veias
5.
J Am Coll Cardiol ; 44(5): 972-9, 2004 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-15337206

RESUMO

OBJECTIVES: This study was designed to utilize optical coherence tomography (OCT) images of coronary atherosclerotic plaque macrophages to investigate the relationship between macrophage distributions and clinical syndrome. BACKGROUND: The relative significance of focal macrophage infiltration and generalized coronary inflammation for predicting acute coronary events is a currently a source of considerable controversy in cardiology. Lack of a high-resolution cross-sectional imaging modality has limited macrophage evaluation in vivo. METHODS: Intracoronary OCT imaging was performed at culprit and non-culprit plaques in patients presenting with stable angina pectoris, unstable angina pectoris,and ST-segment elevation myocardial infarction. Macrophage densities were quantified from these images and analyzed with respect to the clinical presentations of the patients under investigation. RESULTS: A significantly greater macrophage density was found in unstable patients, both for fibrous and lipid-rich plaques (p = 0.025 and p = 0.002, respectively). Within each patient, the macrophage densities at culprit and non-culprit lesions correlated significantly (r = 0.66, y = 0.88x + 0.43, p = 0.01). Sites of plaque rupture demonstrated a greater macrophage density than non-ruptured sites (6.95 +/- 1.60%, 5.29 +/- 1.17%; p = 0.002). Surface macrophage infiltration was a stronger predictor of unstable clinical presentation than subsurface infiltration for culprit lesions (p = 0.035) but not for remote lesions (p = 0.80). CONCLUSIONS: Our results demonstrate that increases in both multi-focal and focal macrophage densities are highly correlated with symptom severity. By providing a means of detecting increases in plaque macrophage content before an acute event, this technique may aid in determining prognosis and guiding preventive therapy.


Assuntos
Doença das Coronárias/patologia , Vasos Coronários/patologia , Macrófagos/patologia , Infarto do Miocárdio/patologia , Tomografia de Coerência Óptica , Idoso , Doença da Artéria Coronariana/patologia , Doença da Artéria Coronariana/fisiopatologia , Doença das Coronárias/fisiopatologia , Feminino , Humanos , Inflamação/patologia , Inflamação/fisiopatologia , Macrófagos/fisiologia , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/fisiopatologia
6.
Cardiovasc Pathol ; 13(2): 85-90, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15033157

RESUMO

Two cases of in-stent restenosis of a coronary artery bypass vein graft following beta (beta) brachytheraphy are presented. Previously unreported histopathology of directed atherectomy specimens of such restenotic lesions and a discussion of their proposed significance form the basis of this report.


Assuntos
Braquiterapia/efeitos adversos , Reestenose Coronária/etiologia , Reestenose Coronária/patologia , Falha de Prótese , Stents , Idoso , Aterectomia Coronária , Partículas beta , Angiografia Coronária , Reestenose Coronária/radioterapia , Oclusão de Enxerto Vascular/etiologia , Oclusão de Enxerto Vascular/patologia , Oclusão de Enxerto Vascular/radioterapia , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade
7.
Catheter Cardiovasc Interv ; 60(4): 458-61, 2003 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-14624421

RESUMO

Contrast-induced nephropathy (CIN) is a common complication of cardiac catheterization, reported to result in a 15% incidence of acute renal failure. Convincing evidence supports the prophylactic use of prehydration and low volumes of contrast medium. Recently, the antioxidant acetylcysteine has been shown to have a potential preventive role. The aim of this study was to examine the hypothesis that acetylcysteine prevents CIN. Patients undergoing cardiac catheterization with a serum creatinine >/= 1.5 mg/dl were prospectively randomized to receive acetylcysteine or placebo. A total of five doses of acetylcysteine 600 mg b.i.d. or placebo was administered, commencing on the day of the procedure. All patients were prehydrated with 0.45% saline and during the catheterization a nonionic low-osmolality contrast medium was used. Serum creatinine and urea were measured at 24, 48, and 72 hr postprocedure. A total of 43 patients were studied. There was no significant difference between the groups in terms of baseline characteristics, including baseline renal function. No adverse events were experienced with acetylcysteine treatment. Serum creatinine levels at 48 and 72 hr remained largely unchanged in the acetylcysteine group but continued to rise at 48 and 72 hr in the placebo group. By 72 hr, the incidence of CIN, defined as a 25% increase in baseline creatinine, was significantly lower in the acetylcysteine arm compared to placebo (5% for acetylcysteine vs. 32% for placebo; P = 0.046). In patients with mild to moderate renal impairment undergoing cardiac catheterization, prophylactic treatment with oral acetylcysteine reduces the incidence of contrast-induced nephropathy.


Assuntos
Acetilcisteína/uso terapêutico , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/prevenção & controle , Meios de Contraste/efeitos adversos , Angiografia Coronária/efeitos adversos , Sequestradores de Radicais Livres/uso terapêutico , Iohexol/análogos & derivados , Idoso , Distribuição de Qui-Quadrado , Meios de Contraste/administração & dosagem , Creatinina/sangue , Feminino , Hidratação , Humanos , Iohexol/administração & dosagem , Iohexol/efeitos adversos , Masculino , Estudos Prospectivos , Estatísticas não Paramétricas , Resultado do Tratamento
8.
Arterioscler Thromb Vasc Biol ; 23(8): 1333-42, 2003 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-12805071

RESUMO

Progress in the diagnosis, treatment, and prevention of atherosclerotic coronary artery disease is dependent on a greater understanding of the mechanisms of coronary plaque progression. Autopsy studies have characterized a subgroup of high-risk, or vulnerable, plaques that result in acute coronary syndromes or sudden cardiac death. These angiographically modest plaques share certain pathologic characteristics: a thin, fibrous cap, lipid-rich core, and macrophage activity. Diagnostic techniques for vulnerable-plaque detection, including serologic markers and noninvasive and invasive techniques, are needed. Recent advances in intravascular imaging have significantly improved the ability to detect high-risk, or vulnerable, plaque in vivo by using various features of plaque vulnerability as methods of identification. The characteristic anatomy of a thin, fibrous cap overlying a lipid pool has promoted high-resolution imaging, such as intravascular ultrasound, optical coherence tomography, and intracoronary magnetic resonance. The lipid-rich core is identifiable by angioscopically detected color changes on the plaque surface or by its unique absorption of energy, or "Raman shift," of its cholesterol core, driving coronary spectroscopy. Finally, temperature heterogeneity arising at foci of plaque inflammation has prompted the development of intracoronary thermography. In this review, we will discuss these techniques, their relative advantages and limitations, and their potential clinical application.


Assuntos
Doença da Artéria Coronariana/diagnóstico , Aumento da Imagem/métodos , Angioscopia/métodos , Artefatos , Angiografia Coronária/métodos , Humanos , Imageamento por Ressonância Magnética , Valor Preditivo dos Testes , Análise Espectral/métodos , Termografia/métodos , Tomografia de Coerência Óptica/métodos , Ultrassonografia de Intervenção/métodos
9.
Curr Atheroscler Rep ; 5(3): 178-85, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12667429

RESUMO

Congestive heart failure represents an enormous clinical problem demanding effective therapeutic approaches. The varied etiologies of heart failure include abnormalities of ion handling, cellular signaling, neurohormonal control, and apoptosis, all of which are potentially amenable to genetic manipulation. Gene therapy holds the promise of retarding the progression, preventing, and perhaps reversing heart failure. Advances in our knowledge of possible targets, vectors, and delivery techniques have revolutionized this field in recent years, bringing us close to clinical application.


Assuntos
Marcação de Genes , Técnicas de Transferência de Genes , Insuficiência Cardíaca/genética , Insuficiência Cardíaca/terapia , Transdução de Sinais/genética , Humanos
10.
Vasc Med ; 7(3): 241-6, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12553747

RESUMO

Strategies to treat atherosclerotic coronary artery disease include coronary artery bypass grafting (CABG), in which grafts are used to bypass atherosclerotic vessels and restore blood flow to the ischemic myocardium. The grafts used include healthy arteries or veins harvested from a separate site. Results with arterial grafts have been superior to venous grafts; promoting the practice of total arterial revascularization using only arterial grafts. Suitable arterial grafts, however, are scarce and harvest procedures add to morbidity and cost. Tissue engineering combines the principles of engineering with life sciences for the development of biological substitutes and restore, maintain or improve tissue function. Advances in this field have included the development of tissue-engineered blood vessels, with the potential to serve as arterial grafts, conduits or fistulae. This review describes the history of tissue engineering arteries, the techniques used, and progress to date. The source of cells and the future direction of this field are explored.


Assuntos
Prótese Vascular , Vasos Sanguíneos/transplante , Prótese Vascular/tendências , Vasos Sanguíneos/patologia , Doença da Artéria Coronariana/cirurgia , Humanos , Estados Unidos , Procedimentos Cirúrgicos Vasculares , Sistema Vasomotor/patologia , Sistema Vasomotor/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...